TANIS BAST: Open Payments
NPI 1295193274 · UNION, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,427 in 199 payments from 15 companies in 2025. Trend: 2023 $1,622 · 2024 $1,587 · 2025 $32,427
Speaker / faculty: $16,860Honoraria: $5,963Travel & lodging: $5,343Food & beverage: $3,701Consulting: $560
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 48 | $21,151 |
| Braeburn Inc. | 46 | $9,526 |
| Otsuka America Pharmaceutical, Inc. | 16 | $318 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $299 |
| ABBVIE INC. | 14 | $262 |
| Indivior Inc. | 14 | $219 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $158 |
| Vanda Pharmaceuticals Inc. | 9 | $150 |
| Axsome Therapeutics, Inc. | 5 | $85 |
| Lundbeck LLC | 5 | $84 |
Products named: VIVITROL, BRIXADI, REXULTI, CAPLYTA, VRAYLAR, SUBLOCADE, XIFAXAN, FANAPT.
Industry payments across MO — which companies pay providers there.
